journal cover

Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell

Annals of Neurology

Jul 18, 2001

Henk W BerendseErik Ch Wolters

PMID: 11456307

Abstract

By the time a clinical diagnosis of Parkinson's disease (PD) is made, a significant loss of dopaminergic neurons has already occurred. Identifying patients in the period between the presumed onset of dopaminergic cell loss and the appearance of clinical parkinsonism may be of major impo...read more

Mentioned in this Paper

Tomography, Emission-Computed, Single-Photon
Smell Perception
Parkinsonian Disorders
Critical Incident Technique
Dopamine transporter
N-(2-fluoroethyl)-2-carbomethoxy-3-(4-iodophenyl)nortropane
Ventricular Dysfunction
Parkinson Disease
Physiopathological
Ligands Activity
1
77
Paper Details
References
  • References35
  • Citations101
1234
  • References35
  • Citations101
12345...

Similar Papers Found In These Feeds

Synucleinopathies

Synucleinopathies are neurodegenerative diseases characterized by accumulation of alpha-synuclein protein aggregates in neurons and glial cells. Discover the latest research on synucleinopathies here.

Inosine: Parkinson's Disease

Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects movement. Drug Inosine is proposed to slow progression of this disease. Here is the latest research on Inosine in PD.

Dopaminergic System

This feed focuses on projection neurons in the brain which are responsible for synthesis and release of neurotransmitter dopamine.

Lewy Body Disease

Lewy Body Disease, associated with abnormal deposits of proteins like alpha-synuclein in the brain, causes a decline in mental abilities. Here is the latest on this progressive neurological disorder.

Parkinson's Disease

Parkinson's Disease is a progressive neurodegenerative disorder characterized by loss of muscle control, including trembling of the limbs and impaired balance. Here is the latest research.

Dopamine & Behavior

Dopamine is a neurotransmitter and a hormone commonly associated with the brain's pleasure and reward system. Here is the latest research on its role in affecting and guiding human behaviour.

Related Papers

Annals of Neurology

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

Annals of NeurologyAugust 5, 2004
Mirthe M PonsenHenk W Berendse
© 2020 Meta ULC. All rights reserved

Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell

Annals of Neurology

Jul 18, 2001

Henk W BerendseErik Ch Wolters

PMID: 11456307

DOI:

Abstract

By the time a clinical diagnosis of Parkinson's disease (PD) is made, a significant loss of dopaminergic neurons has already occurred. Identifying patients in the period between the presumed onset of dopaminergic cell loss and the appearance of clinical parkinsonism may be of major impo...read more

Mentioned in this Paper

Tomography, Emission-Computed, Single-Photon
Smell Perception
Parkinsonian Disorders
Critical Incident Technique
Dopamine transporter
N-(2-fluoroethyl)-2-carbomethoxy-3-(4-iodophenyl)nortropane
Ventricular Dysfunction
Parkinson Disease
Physiopathological
Ligands Activity
1
77

Similar Papers Found In These Feeds

Synucleinopathies

Synucleinopathies are neurodegenerative diseases characterized by accumulation of alpha-synuclein protein aggregates in neurons and glial cells. Discover the latest research on synucleinopathies here.

Inosine: Parkinson's Disease

Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects movement. Drug Inosine is proposed to slow progression of this disease. Here is the latest research on Inosine in PD.

Related Papers

Annals of Neurology

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

Annals of NeurologyAugust 5, 2004
Mirthe M PonsenHenk W Berendse
Paper Details
References
  • References35
  • Citations101
1234
  • References35
  • Citations101
12345...
/papers/subclinical-dopaminergic-dysfunction-in/11456307